Becton, Dickinson and Company EBITDA Margin

EBITDA Margin of BDX for past 10 years: annual, quarterly and twelve month trailing (TTM) including EBITDA Margin growth rates and interactive chart.


Highlights and Quick Summary

  • EBITDA Margin for the quarter ending September 30, 2022 was 20.32% (a -11.96% decrease compared to previous quarter)
  • Year-over-year quarterly EBITDA Margin decreased by -26.08%
  • Annual EBITDA Margin for 2022 was 23.91% (a 2.09% increase from previous year)
  • Annual EBITDA Margin for 2021 was 23.42% (a 24.38% increase from previous year)
  • Annual EBITDA Margin for 2020 was 18.83% (a -18.87% decrease from previous year)
  • Twelve month EBITDA Margin ending September 30, 2022 was 23.91% (a 4.87% increase compared to previous quarter)
  • Twelve month trailing EBITDA Margin increased by 10.85% year-over-year
Trailing EBITDA Margin for the last four month:
30 Sep '22 30 Jun '22 31 Mar '22 31 Dec '21
23.91% 22.8% 22.61% 21.57%
Visit stockrow.com/BDX for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical EBITDA Margin of Becton, Dickinson and Company

Most recent EBITDA Marginof BDX including historical data for past 10 years.

Interactive Chart of EBITDA Margin of Becton, Dickinson and Company

Becton, Dickinson and Company EBITDA Margin for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 20.32% 23.08% 24.15% 23.91%
2021 27.49% 15.48% 22.29% 20.2% 23.42%
2020 33.81% 5.27% 23.16% 21.3% 18.83%
2019 24.4% 14.5% 27.59% 16.66% 23.21%
2018 34.83% 25.94% 25.22% 17.53% 21.82%
2017 17.08% 24.53% 1.81% 23.78% 21.58%
2016 36.69% 11.45% 24.64% 24.29% 20.38%
2015 21.47% 19.93% 13.97% 21.01% 19.11%
2014 23.79% 24.98% 27.21% 24.66% 25.67%
2013 25.81% 10.42% 26.5% 25.85% 22.36%
2012 27.42% 26.25% 28.87% 26.5% 26.84%

Business Profile of Becton, Dickinson and Company

Sector: Healthcare
Industry: Medical Instruments & Supplies